Researchers at Children's Hospital Boston have found a marker called ABCB5 that both tags a small proportion of cells within colorectal cancers and fuels resistance in those cells to standard treatments. The results indicate ...
Jun 8, 2011
0
0
The nature of the connective tissue surrounding lung cancer nests can help predict the aggressiveness of squamous cell carcinoma, according to research published in the September issue of the Journal of Thoracic Oncology, ...
Sep 1, 2011
0
0
The pattern of genomic alterations in colon and rectal tissues is the same regardless of anatomic location or origin within the colon or the rectum, leading researchers to conclude that these two cancer types can be grouped ...
Jul 18, 2012
0
0
Why do people respond differently to infections or vaccines? Why are some people allergic to pollen? These are still unanswered questions in immune studies. A research consortium led by CNRS research director Dr. Lluis Quintana-Murci ...
Mar 1, 2018
0
21
The 21st century has already seen multiple major new disease outbreaks, from SARS and MERS to Ebola and Zika, culminating in the current COVID-19 pandemic. The global human suffering, economic damage, and social disruption ...
Jun 25, 2020
0
103
A technique using live human cancer tissue to develop the next generation of cancer drugs is being developed in South Australia.
Aug 22, 2018
0
29
In the E coli outbreak in Germany in May 2011, treatment with azithromycin was associated with a lower frequency of long-term carriage of the bacteria and shorter duration of shedding of the bacteria in stool specimens, according ...
Mar 13, 2012
0
0
When Dr. Peter Lee leaves his Brown University lab and looks up into the night sky, he can sometimes catch a glimpse of his own research project.
Apr 6, 2023
0
2
Testing for novel protein biomarkers in stool finds significantly more colorectal cancers (CRC) and advanced adenomas (precursors to cancer) compared to testing for hemoglobin alone. The proteins can be detected in a small ...
Nov 20, 2017
0
1
Knowing what type of lung cancer a patient has is critical to determine which drug will work best and which therapies are safest in the era of personalized medicine. Key to making that judgment is an adequate tumor specimen ...
Jul 16, 2013
0
0
